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Abstract 
Objective: To determine the possible risk factors for temporomandibular disorders (TMD) 
among amphetamine users in Indonesia. Material and Methods: This cross-sectional study 
involved 152 male amphetamine users, aged 18-45 years, who were undergoing rehabilitation. 
Data were obtained from medical records, questionnaires, and clinical examinations. Data 
obtained from medical records included age, gender, duration of amphetamine use, duration of 
rehabilitation, and psychiatric status. Collected data were analyzed using the Chi-square and 
logistic regression tests to identify correlations between TMD and bruxism, oral habits, tooth 
wear, duration of amphetamine abused, and duration of rehabilitation. Results: TMD was found 
in 84.2% of amphetamine users, with clicking being the most frequently reported sign (72.4%). 
Tooth wear (72.4%), oral habits (60.5%), and bruxism (56.6%) were also frequently found. 
Statistically, a significant association was found between TMD and bruxism (p<0.001), tooth 
wear (p<0.001), and oral habits (p<0.001). However, there was no association observed between 
TMD and duration of amphetamine abused (p=0.526), and duration of rehabilitation (p=0.679). 
Odds ratios produced by logistic regression for tooth wear, oral habits, and bruxism were 6.657, 
6.2, and 1.659, respectively. Conclusion: Tooth wear, oral habits, and bruxism were identified as 
risk factors for TMD among amphetamine users in Indonesia. 
 
Keywords: Temporomandibular Joint Disorders; Oral Health; Drug Users.
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Introduction 
Temporomandibular disorders (TMD) compose a set of joint and muscular dysfunctions of 
the cranio-orofacial area, characterized by joint and/or muscular pain, noise in the 
temporomandibular joints, and limited mandibular movement. The prevalence of TMD varies widely 
in the literature, ranging from 7% to 85%. In females, the prevalence is 1.5–2-fold higher than that 
reported in males [1]. The etiology of TMD is multifactorial and complex, including occlusal 
disharmonies, parafunction, trauma, deep pain input, and stress [2]. Activities causing excessive and 
continuous loading to the masticatory joint and muscles may lead to TMD. Drug users are 
susceptible to such joint and muscle loading and have a significantly higher prevalence of TMD [3]. 
According to a national survey conducted in 2004, 1.5% of the Indonesian population aged 
15–64 years have ever used drugs. The most commonly abused substance reported in the survey was 
cannabis and amphetamines. Amphetamines are potent and addictive stimulants of the central 
nervous system (CNS). They stimulate the CNS by increasing the release of catecholaminergic 
neurotransmitters [3]. This results in a feeling of higher energy, focus, confidence, and euphoria. 
Types of amphetamines commonly abused in Indonesia include crystalline methamphetamine (sabu-
sabu) and 3,4-methylenedioxymethamphetamine (MDMA or ecstasy). The use of amphetamine-type 
stimulants, particularly crystalline methamphetamine, has expanded throughout Indonesia. In 2011, 
it was estimated that 1.2 million individuals used crystalline methamphetamine, while 950.000 
individuals used ecstasy during the year in Indonesia [4]. 
Many studies, surveys, and case reports have described the social, medical, and oral effects of 
drug abuse. However, there are currently no studies investigating the development of TMD among 
amphetamine users in Indonesia. It was suggested that amphetamine addicts perform typical, 
continuous movements, and rub the tongue along the inside of the lower lip. In addition, it was later 
reported that bruxism is an adverse effect of amphetamines. Users of ecstasy had a higher prevalence 
and severity of tooth wear compared with nonusers, with 89% of those reporting clenching or 
grinding after consuming the drug [5]. Occlusal overloading and bruxism are frequently involved as 
biomechanical factors that may contribute to TMD. The purpose of this study was to determine the 
risk factors for TMD among amphetamine users in Indonesia. 
 
Material and Methods 
Study Design and Sample 
A total of 152 male amphetamine users, aged 18–45 years (29.72 ± 6.73 years), who were 
undergoing rehabilitation participated in this cross-sectional study. 
The study was conducted in March 2018 at the National Rehabilitation Center, Lido, West 
Java, Indonesia (Balai Besar Rehabilitasi Badan Narkotika Nasional). The inclusion criteria were: (1) 
age between 18 and 45 years, (2) history of amphetamine use, (3) presence of incisor, canine, 
premolar, and molar, (4) no history of facial or cervical injury, and (5) no history of general 
neurologic, hormonal, psychiatric, or neoplasm diseases. 
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Data Collection 
Data obtained from medical records included age, gender, duration of amphetamine use, 
duration of rehabilitation, and psychiatric status. Subjects meeting the inclusion criteria and 
voluntarily expressing the desire to participate in this study were enrolled. 
Questionnaires validated in the Indonesian version and clinical examination were used to 
collect data. Three questionnaires, i.e., TMD - Diagnostic Index (TMD-DI), sleep bruxism 
questionnaire established by the American Academy of Sleep Medicine, and bad habits questionnaire 
from etiology of TMD index were completed by the subjects [6-8]. Clinical examination, i.e., 
palpation of the temporal and masseter muscles (1 kg of pressure), palpation of TMJ (0.5 kg of 
pressure), joint clicking during movement (opening and closing) of the jaws, and limited mouth 
opening (<40 mm including overbite) were assessed by an experienced examiner according to the 
DC-TMD [9]. Tooth wear was examined visually and classified according to a 6-point scale (0: no 
apparent wear, 1: slight wear, 2: wear of enamel only, 3: wear into the dentin in a single spot, 4: 
exposure of dentin in an area >2 mm2, and 5: wear of more than one third of the clinical crown). The 
highest score for each of the four dental regions (incisors, canines, premolars, and molars) at the 
upper and lower jaws was recorded. Subjects with a score of 3 in at least one region were defined as 
having tooth wear [10]. 
 
Statistical Analysis 
The IBM SPSS Statistics Software, version 22 (IBM Corp., Armonk, NY, USA) was used to 
analyze the data. Bivariate analysis using the Chi-square test for qualitative variables (TMD, 
bruxism, oral habits, tooth wear, duration of amphetamine use, and duration of rehabilitation) was 
performed. Multivariate analysis using logistic regression was performed to determine the risk 
factors for TMD among amphetamine users. The level of significance was set at p<0.05. 
 
Ethical Aspects 
This study was approved by the Ethics Committee of the Faculty of Dentistry, Universitas 
Indonesia. All subjects provided written informed consent prior to their participation in the study. 
 
Results 
TMD was found in 84.2% of the subjects, with joint clicking being the most frequently 
reported sign (70.4%). Tooth wear (72.4%), oral habits (60.5%), and bruxism (56.6%) were also 
frequently found among the subjects (Table 1). 
 
Table 1. Sample distribution according to clinical variables. 
Variables N % 
TMD   
No 24 15.8 
Yes 128 84.2 
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Bruxism   
No 66 43.4 
Yes 86 56.6 
Oral Habits   
No 60 39.5 
Yes 92 60.5 
Tooth Wear   
No 42 27.6 
Yes 110 72.4 
Duration of Amphetamine Use   
≤ 3 Years 35 23.0 
> 3 – ≤ 5 Years 38 25.0 
> 5 Years 79 52.0 
Duration of Rehabilitation   
≤3 Months 86 56.6 
>3 Months 66 43.4 
Muscle Pain   
No 139 91.4 
Yes 13 8.6 
TMJ Pain   
No 146 96.1 
Yes 6 3.9 
Joint Clicking   
No 45 29.6 
Yes 107 70.4 
Mouth Limited Opening   
No 142 93.4 
Yes 10 6.6 
 
It was found a statistically significant association between TMD and tooth wear, bruxism, 
and oral habits (p<0.001). However, there was no statistically significant association observed 
between TMD and the duration of amphetamine used or the duration of rehabilitation (Table 2). 
 
Table 2. Associations between TMD and risk factors. 
Variables Non-TMD TMD p-value 
 N (%) N (%)  
Bruxism    
No 20 (30.3) 46 (69.0) <0.001* 
Yes 4 (4.7) 82 (95.3)  
Oral Habits     
No 20 (33.3) 40 (66.7) <0.001* 
Yes 4 (4.3) 88 (95.7)  
Tooth Wear    
No 18 (42.9) 24 (57.1) <0.001* 
Yes 6 (5.5) 104 (94.5)  
Duration of Amphetamine Use    
≤ 3 Years 7 (20.0) 28 (80.0) 0.526** 
>3 – ≤5 4 (10.5) 36 (89.5)  
> 5 Years 13 (16.5) 66 (83.5)  
Duration of Rehabilitation    
≤ 3 Months 15 (17.4) 71 (82.6) 0.679* 
> 3 Months 9 (13.6) 57 (86.4)  
*Continuity Correction test; **Pearson Chi-square test. 
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Multivariate analysis was performed using the enter method of logistic regression to 
determine the odds ratio (OR) of possible risk factors for TMD among amphetamine users in 
Indonesia. The variables included bruxism, tooth wear, and oral habits (p<0.25). This model had a 
value of Hosmer and Lemeshow test (p = 0.395), indicating that the model was supported by 
empirical data (fit model). The OR produced by this analysis for tooth wear, oral habits, and bruxism 
were 6.573, 6.2, and 1.649, respectively (Table 3). 
 
Table 3. Logistic regression analysis. 
Variables B Exp(B) p-value 
Bruxism 0.500 1.649 0.499 
Tooth Wear 1.883 6.573 0.003 
Oral Habits 1.825 6.200 0.003 
 
Discussion 
This was the first investigation regarding the development of TMD among amphetamine 
users in Indonesia. A high prevalence of TMD was found among subjects, and an association was 
detected between TMD and bruxism [11]. These findings are consistent with those of a previous 
study, showing a high prevalence of TMD signs and symptoms, nocturnal clenching, and diurnal 
clenching in an addicted population compared with those reported in control subjects [11]. It is 
reported in the literature that amphetamine use results in bruxism [12]. Jaw tension and tooth 
grinding are two of the ten most frequently reported side effects of ecstasy use [13]. 
Moreover, another study showed an association between bruxism and methamphetamine use 
[14]. Amphetamine increases the release of dopamine in the brain. The central dopaminergic system 
plays a role in the pathophysiology of sleep bruxism [15]. The detection of sleep bruxism in this 
study was achieved through the use of a questionnaire. Direct detection of bruxing activity through 
the use of polysomnography may reach a more accurate diagnosis; however, this type of investigation 
was not applicable in the present study. 
An association between TMD and tooth wear was also found in this study. This result was 
consistent with those of a previous study showing a higher prevalence of tooth wear among ecstasy 
users than that reported among nonusers. The investigators concluded that the combination of 
ecstasy induced-bruxism, dry mouth, and the erosive effects of carbonated drinks consumed while 
using ecstasy resulted in more advanced tooth wear [16]. Another variable shown to be significantly 
associated with TMD in the present study was oral habits. Oral habits, including parafunction 
activity, is one of the etiologies of TMD [2]. Some authors reported a significant association 
between signs and/or symptoms of TMD and harmful oral habits (nail-biting, lip/object biting, and 
grinding of the teeth) among adolescents [17]. Moreover, it was found a significant association 
between the duration of addiction and habits of jaw play, gum chewing, and daytime clenching 
among drug addicts. 
Logistic regression analysis showed that tooth wear, oral habits, and bruxism were 
associated with the occurrence of TMD among amphetamine users in Indonesia. Based on the OR, it 
 Pesqui. Bras. Odontopediatria Clín. Integr. 2019; 19:e5261 
 
6 
may be concluded that subjects with tooth wear had a 6.57-fold higher risk of developing TMD than 
those without tooth wear. In addition, subjects with oral habits had a 6.20-fold higher risk of 
developing TMD than those without oral habits. Moreover, subjects with bruxism had a 1.65-fold 
higher risk of developing TMD than those without bruxism. 
In the present study, bruxism was the weakest risk factor for TMD. The assessment of 
bruxism was based only on the relevant questionnaire. Thus, the present results may not represent 
bruxism as a direct effect while under the influence of amphetamines. However, tooth wear – the 
strongest risk factor reported in this study – is a specific marker of bruxism. A study involving 
amphetamine users and a similar design to the present investigation showed that regular users of 
amphetamines exhibit significantly greater tooth wear than nonusers. The matching of the two study 
groups suggests that tooth wear may be attributed to drug use rather than other causes [18]. The 
extent of tooth wear may also be influenced by the density of enamel, quality of saliva, or efficacy of 
lubrication [19]. Dry mouth is another common side effect of amphetamine use [16], which may be 
an exacerbating factor for tooth wear among amphetamine users. The combination of bruxism and 
dry mouth may explain the importance of tooth wear as a risk factor for TMD among amphetamine 
users. 
This study was conducted in subjects who were undergoing rehabilitation for ≥1 month. 
Therefore, the presence and the cause (i.e., drug abuse or other more recent factors) of TMD must be 
interpreted cautiously. Drug abuse is an illegal and taboo activity in Indonesia. Thus, it is difficult to 
conduct a study involving active users. However, considering the lack of association between TMD 
and the duration of rehabilitation, it is hypothesized that the rehabilitation period may not influence 
the outcome of this study. 
 
Conclusion 
Tooth wear, oral habits, and bruxism were identified as risk factors for the development of 
TMD among amphetamine users in Indonesia. Amphetamine users with tooth wear had a 6.57-fold 
higher risk of developing TMD than those without tooth wear. In addition, subjects with oral habits 
had a 6.20-fold higher risk of developing TMD than those without oral habits. Moreover, subjects 
with bruxism had a 1.65-fold higher risk of developing TMD than those without bruxism.  
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